[144] Blue Bird Corporation SEC Filing
Blue Bird Corporation (BLBD) submitted a Form 144 notice for the proposed sale of 30,000 common shares through UBS Financial Services with an aggregate market value of $1,800,000. The 30,000 shares represent approximately 0.095% of the 31,707,943 shares outstanding. The shares were acquired on 06/08/2016 by RSU vesting. The filing lists prior sales in June 2025 of 8,860 shares (06/10/2025, $363,614), 13,289 shares (06/11/2025, $554,106.93) and 14,875 shares (06/12/2025, $615,527.50), totaling 37,024 shares and $1,533,248.43 in gross proceeds over the past three months. The proposed sale date is approximately 08/08/2025 on NASDAQ. The filer affirms no undisclosed material information in the remarks.
- None.
- None.
Insights
TL;DR Routine insider sale; size is immaterial to capitalization but should be disclosed and monitored.
The proposed sale of 30,000 shares equals roughly 0.095% of outstanding stock, indicating a small insider liquidity event rather than a material divestiture. Prior June transactions total 37,024 shares (about 0.117% of outstanding) generating $1.53M in proceeds, showing ongoing incremental selling. The filing transparently notes acquisition by RSU vesting in 2016 and uses UBS as broker. From a market-impact perspective, these volumes are unlikely to move the stock but are relevant for tracking insider selling patterns.
TL;DR Filing demonstrates procedural compliance with Rule 144 and records RSU-originated shares; no governance red flags evident.
The notice documents the grant origin (RSU vesting), acquisition date, and planned sale through an institutional broker, consistent with Rule 144 disclosure practices. The filer also signs the customary representation about lacking undisclosed material information. Absent other context such as executive departures or regulatory issues in this filing, the disclosure appears compliant and routine from a governance perspective.